Michael Callaghan, MD
Director, Sickle Cell Center
Associate Professor of Pediatrics
Children’s Hospital of Michigan
Tami L. Bach, MD, PhD
Clinical Assistant Professor of Medicine
Penn Comprehensive Hemophilia Program
Penn Blood Disorders Center
The University of Pennsylvania
The podcast will cover the treatment and management of patients with hemophilia A.
This activity is designed to meet the educational needs of hematologists who treat patients with hemophilia A.
After completing the CME activity, learners should be better able to:
- Assess traditional management approaches for those with hemophilia A including the potential for immunogenicity
- Describe the mechanisms of action and efficacy and safety profiles of recently approved and emerging non-factor replacement therapies for patients with hemophilia A
- Implement individualized prophylaxis management strategies using non-factor replacement therapies based on patient characteristics
- Adopt patient-centered, shared decision-making approaches to the management of hemophilia A
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this online podcast activity for a maximum of 0.5 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the online podcast activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with hemophilia A. Credits: 0.5 ANCC Contact Hour
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 0.5 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Dr. Callaghan has received consulting fees from Roche/Genentech, Takeda, Bayer, Pfizer, Novo Nordisk, Grifols, Kedrion, Spark, Biomarin, Hema Biologics, Global Blood Therapeutics, and Bioverativ/Sanofi. He has served on the speakers’ bureau for Roche/Genentech, Bayer, Novo Nordisk and Takeda. He has been contracted for research with Roche/Genentech, Pfizer, Global Blood Therapeutics, Sancillio, Amgen, and Biomarin and has ownership interest in Alnyum.
Dr. Bach has nothing to disclose.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CNE activity:
Staff Planners and Managers:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Brianna Hanson, Outcomes and Accreditation Coordinator for Med Learning Group has nothing to disclose.
Nicole Longo, DO, FACOI, Director, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this online podcast activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the online podcast activity.
- Complete the post-test and evaluation.
You will receive your certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
RELEASE DATE: September 29, 2020
EXPIRATION DATE: September 29, 2021
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.